Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

SRx Health Solutions (SRXH) Capital Expenditures (2019 - 2025)

SRx Health Solutions' Capital Expenditures history spans 7 years, with the latest figure at $7000.0 for Q1 2025.

For Q1 2025, Capital Expenditures rose 133.33% year-over-year to $7000.0; the TTM value through Mar 2025 reached $3.5 million, up 31854.55%, while the annual FY2023 figure was $18000.0, 90.91% down from the prior year.
Capital Expenditures reached $7000.0 in Q1 2025 per SRXH's latest filing, down from $11000.0 in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $3.5 million in Q2 2024 to a low of $3000.0 in Q1 2024.
Average Capital Expenditures over 5 years is $340333.3, with a median of $25000.0 recorded in 2022.
Peak YoY movement for Capital Expenditures: surged 2800.0% in 2021, then tumbled 93.33% in 2023.
A 5-year view of Capital Expenditures shows it stood at $229000.0 in 2021, then plummeted by 96.07% to $9000.0 in 2022, then fell by 11.11% to $8000.0 in 2023, then soared by 37.5% to $11000.0 in 2024, then tumbled by 36.36% to $7000.0 in 2025.
Per Business Quant, the three most recent readings for SRXH's Capital Expenditures are $7000.0 (Q1 2025), $11000.0 (Q3 2024), and $3.5 million (Q2 2024).